Abstract
P-091: Genome-wide CRISPR/Cas9 screening identifies proteasome-related specific vulnerabilities as potential treatment options of proteasome inhibitor-resistant multiple myeloma
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have